haidut
Member
The study focuses on cabergoline (a prolactin lowering drug with dopaminergic qualities), however the abstract discusses positive results with other anti-prolactin drugs like bromocriptine. In light of the recent study showing serotonin inhibition treating obesity, this is yet another confirmation that pro-dopaminergic therapies improve metabolism and thus obesity.
The dose used in this study was pretty reasonable - <1mg cabergoline per week, split in 2 or more doses. So, something like 0.5mg cabergoline taken twice a week should work and is in fact pretty standard first like therapy for lowering prolactin.
http://onlinelibrary.wiley.com/doi/10.1 ... 03.46/full
The dose used in this study was pretty reasonable - <1mg cabergoline per week, split in 2 or more doses. So, something like 0.5mg cabergoline taken twice a week should work and is in fact pretty standard first like therapy for lowering prolactin.
http://onlinelibrary.wiley.com/doi/10.1 ... 03.46/full